Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Cytosolic phospholipase A₂ alpha (cPLA₂α) is an essential enzyme regulating membrane lipid metabolism with broad implications for inflammatory signaling pathways. Its unique structure enables precise regulation via calcium signals and kinase-mediated phosphorylation. As both a key initiator of eicosanoid biosynthesis and an important player in disease pathogenesis—including chronic inflammation, cancer progression, cardiovascular disorders, and viral infections—cPLA₂α remains an attractive target for therapeutic intervention despite challenges related to inhibitor specificity.
Inhibition of arachidonic acid release
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Cytosolic Phospholipase A2 Alpha (cPLA2α).